CSPC Innovation Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2023: USD 130.60 M

CSPC Innovation Pharmaceutical Co., Ltd. Operating Cash Flow is USD 130.60 M for the year ending December 31, 2023, a 40.66% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • CSPC Innovation Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 92.85 M, a 245.82% change year over year.
  • CSPC Innovation Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 26.85 M, a -49.80% change year over year.
  • CSPC Innovation Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 53.48 M, a 18.08% change year over year.
  • CSPC Innovation Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2019 was USD 45.29 M, a 95.01% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities